Dale C Hesdorffer1, Shlomo Shinnar2, Daniel N Lax2, John M Pellock3, Douglas R Nordli4, Syndi Seinfeld3, William Gallentine5, L Matthew Frank6, Darrell V Lewis5, Ruth C Shinnar2, Jacqueline A Bello7, Stephen Chan8, Leon G Epstein4, Solomon L Moshé2, Binyi Liu1, Shumei Sun9. 1. Department of Epidemiology and GH Sergievsky Center, Columbia University, New York, New York, U.S.A. 2. Departments of Neurology and Pediatrics, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, U.S.A. 3. Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, U.S.A. 4. Department of Neurology, Ann & Robert H. Lurie Children's Hospital of Chicago, Illinois, U.S.A. 5. Department of Pediatrics (Neurology), Duke University Medical Center, Durham, North Carolina, U.S.A. 6. Department of Neurology, Children's Hospital of The King's Daughters and Eastern Virginia Medical School, Norfolk, Virginia, U.S.A. 7. Department Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, U.S.A. 8. Department of Radiology, Columbia University, New York, New York, U.S.A. 9. Department of Biostatistics and International Epilepsy Consortium, Virginia Commonwealth University, Richmond, Virginia, U.S.A.
Abstract
OBJECTIVES: To identify risk and risk factors for developing a subsequent febrile seizure (FS) in children with a first febrile status epilepticus (FSE) compared to a first simple febrile seizure (SFS). To identify home use of rescue medications for subsequent FS. METHODS: Cases included a first FS that was FSE drawn from FEBSTAT and Columbia cohorts. Controls were a first SFS. Cases and controls were classified according to established FEBSTAT protocols. Cumulative risk for subsequent FS over a 5-year period was compared in FSE versus SFS, and Cox proportional hazards regression was conducted. Separate analysis examined subsequent FS within FSE. The use of rescue medications at home was assessed for subsequent FS. RESULTS: Risk for a subsequent FSE was significantly increased in FSE versus SFS. Any magnetic resonance imaging (MRI) abnormality increased the risk 3.4-fold (p < 0.05), adjusting for age at first FS and FSE and in analyses restricted to children whose first FS was FSE (any MRI abnormality hazard ratio [HR] 2.9, p < 0.05). The risk for a second FS of any type or of subsequent FS lasting >10 min over the 5-year follow-up did not differ in FSE versus SFS. Rectal diazepam was administered at home to 5 (23.8%) of 21 children with subsequent FS lasting ≥10 min. SIGNIFICANCE: Compared to controls, FSE was associated with an increased risk for subsequent FSE, suggesting the propensity of children with an initial prolonged seizure to experience a prolonged recurrence. Any baseline MRI abnormality increased the recurrence risk when FSE was compared to SFS and when FSE was studied alone. A minority of children with a subsequent FS lasting 10 min or longer were treated with rectal diazepam at home, despite receiving prescriptions after the first FSE. This indicates the need to further improve the education of clinicians and parents in order to prevent subsequent FSE. Wiley Periodicals, Inc.
OBJECTIVES: To identify risk and risk factors for developing a subsequent febrile seizure (FS) in children with a first febrile status epilepticus (FSE) compared to a first simple febrile seizure (SFS). To identify home use of rescue medications for subsequent FS. METHODS: Cases included a first FS that was FSE drawn from FEBSTAT and Columbia cohorts. Controls were a first SFS. Cases and controls were classified according to established FEBSTAT protocols. Cumulative risk for subsequent FS over a 5-year period was compared in FSE versus SFS, and Cox proportional hazards regression was conducted. Separate analysis examined subsequent FS within FSE. The use of rescue medications at home was assessed for subsequent FS. RESULTS: Risk for a subsequent FSE was significantly increased in FSE versus SFS. Any magnetic resonance imaging (MRI) abnormality increased the risk 3.4-fold (p < 0.05), adjusting for age at first FS and FSE and in analyses restricted to children whose first FS was FSE (any MRI abnormality hazard ratio [HR] 2.9, p < 0.05). The risk for a second FS of any type or of subsequent FS lasting >10 min over the 5-year follow-up did not differ in FSE versus SFS. Rectal diazepam was administered at home to 5 (23.8%) of 21 children with subsequent FS lasting ≥10 min. SIGNIFICANCE: Compared to controls, FSE was associated with an increased risk for subsequent FSE, suggesting the propensity of children with an initial prolonged seizure to experience a prolonged recurrence. Any baseline MRI abnormality increased the recurrence risk when FSE was compared to SFS and when FSE was studied alone. A minority of children with a subsequent FS lasting 10 min or longer were treated with rectal diazepam at home, despite receiving prescriptions after the first FSE. This indicates the need to further improve the education of clinicians and parents in order to prevent subsequent FSE. Wiley Periodicals, Inc.
Authors: Syndi Seinfeld; Shlomo Shinnar; Shumei Sun; Dale C Hesdorffer; Xiaoyan Deng; Ruth C Shinnar; Kathryn O'Hara; Douglas R Nordli; L Matthew Frank; William Gallentine; Solomon L Moshé; John M Pellock Journal: Epilepsia Date: 2014-02-06 Impact factor: 5.864
Authors: A T Berg; S Shinnar; A S Darefsky; T R Holford; E D Shapiro; M E Salomon; E F Crain; A W Hauser Journal: Arch Pediatr Adolesc Med Date: 1997-04
Authors: Darrell V Lewis; Daniel P Barboriak; James R MacFall; James M Provenzale; Teresa V Mitchell; Kevan E VanLandingham Journal: Prog Brain Res Date: 2002 Impact factor: 2.453
Authors: Dale C Hesdorffer; Shlomo Shinnar; Darrell V Lewis; Solomon L Moshé; Douglas R Nordli; John M Pellock; James MacFall; Ruth C Shinnar; David Masur; L Matthew Frank; Leon G Epstein; Claire Litherland; Syndi Seinfeld; Jacqueline A Bello; Stephen Chan; Emilia Bagiella; Shumei Sun Journal: Epilepsia Date: 2012-06-28 Impact factor: 5.864
Authors: William H Theodore; Leon Epstein; William D Gaillard; Shlomo Shinnar; Mark S Wainwright; Steven Jacobson Journal: Epilepsia Date: 2008-07-08 Impact factor: 5.864
Authors: Eugen Trinka; Hannah Cock; Dale Hesdorffer; Andrea O Rossetti; Ingrid E Scheffer; Shlomo Shinnar; Simon Shorvon; Daniel H Lowenstein Journal: Epilepsia Date: 2015-09-04 Impact factor: 5.864
Authors: S Shinnar; D C Hesdorffer; D R Nordli; J M Pellock; C O'Dell; D V Lewis; L M Frank; S L Moshé; L G Epstein; A Marmarou; E Bagiella Journal: Neurology Date: 2008-06-04 Impact factor: 9.910